IRhythm Technologies Income from Continuous Operations 2015-2025 | IRTC
IRhythm Technologies annual/quarterly income from continuous operations history and growth rate from 2015 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- IRhythm Technologies income from continuous operations for the quarter ending June 30, 2025 was $-0.014B, a 29.29% decline year-over-year.
- IRhythm Technologies income from continuous operations for the twelve months ending June 30, 2025 was $-0.092B, a 29.76% decline year-over-year.
- IRhythm Technologies annual income from continuous operations for 2024 was $-0.113B, a 8.2% decline from 2023.
- IRhythm Technologies annual income from continuous operations for 2023 was $-0.123B, a 6.24% increase from 2022.
- IRhythm Technologies annual income from continuous operations for 2022 was $-0.116B, a 14.6% increase from 2021.
| IRhythm Technologies Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-113 |
| 2023 | $-123 |
| 2022 | $-116 |
| 2021 | $-101 |
| 2020 | $-44 |
| 2019 | $-55 |
| 2018 | $-50 |
| 2017 | $-30 |
| 2016 | $-21 |
| 2015 | $-23 |
| 2014 | $-16 |
| IRhythm Technologies Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-06-30 | $-14 |
| 2025-03-31 | $-31 |
| 2024-12-31 | $-1 |
| 2024-09-30 | $-46 |
| 2024-06-30 | $-20 |
| 2024-03-31 | $-46 |
| 2023-12-31 | $-39 |
| 2023-09-30 | $-27 |
| 2023-06-30 | $-18 |
| 2023-03-31 | $-39 |
| 2022-12-31 | $-20 |
| 2022-09-30 | $-21 |
| 2022-06-30 | $-24 |
| 2022-03-31 | $-51 |
| 2021-12-31 | $-32 |
| 2021-09-30 | $-24 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-28 |
| 2020-12-31 | $-10 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-20 |
| 2020-03-31 | $-9 |
| 2019-12-31 | $-17 |
| 2019-09-30 | $-18 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-17 |
| 2018-09-30 | $-10 |
| 2018-06-30 | $-12 |
| 2018-03-31 | $-11 |
| 2017-12-31 | $-11 |
| 2017-09-30 | $-7 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-5 |
| 2016-12-31 | $-6 |
| 2016-09-30 | $-4 |
| 2016-06-30 | $-4 |
| 2016-03-31 | $-6 |
| 2015-12-31 | |
| 2015-09-30 | $-6 |
| 2015-06-30 | $0 |
| 2014-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.159B | $0.592B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.855B | 58.34 |
| Tempus AI (TEM) | United States | $12.818B | 0.00 |
| Doximity (DOCS) | United States | $12.199B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $10.401B | 85.22 |
| Hinge Health (HNGE) | United States | $4.608B | 0.00 |
| Privia Health (PRVA) | United States | $2.610B | 193.36 |
| Inspire Medical Systems (INSP) | United States | $2.596B | 38.16 |
| Heartflow (HTFL) | $2.530B | 0.00 | |
| Phreesia (PHR) | United States | $1.708B | 0.00 |
| Enovis (ENOV) | United States | $1.689B | 8.93 |
| 10x Genomics (TXG) | United States | $1.663B | 0.00 |
| Omnicell (OMCL) | United States | $1.456B | 28.04 |
| Schrodinger (SDGR) | United States | $1.426B | 0.00 |
| Azenta (AZTA) | United States | $1.393B | 60.78 |
| Clover Health Investments (CLOV) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.180B | 0.00 |
| Evolent Health (EVH) | United States | $1.092B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.491B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.429B | 128.00 |
| Carlsmed (CARL) | $0.360B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.360B | 0.00 |
| TruBridge (TBRG) | United States | $0.289B | 50.74 |
| Outset Medical (OM) | United States | $0.236B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.212B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.205B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.193B | 0.00 |
| CapsoVision (CV) | United States | $0.178B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.135B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.110B | 5.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.069B | 0.00 |
| Pulmonx (LUNG) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.023B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |